DMYD B
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Diamyd Medical is active in diabetes research. The company has developed a vaccine that contains the active ingredient and molecule GAD, a substance that has the potential to be an important part of the prevention of diabetes treatments in the future. The company has operations on a global level with the largest presence in the Nordic region. The headquarters are located in Stockholm.
Læs mereOmsætning t
EBIT-% (adj.)
EPS (adj.)
Udbytte %
Delårsrapport Q3'26
Årsrapport '26
Generalforsamling '26
Gå ikke glip af noget - opret en konto og få alle de mulige fordele